시장보고서
상품코드
1677855

임상시험 지원 서비스 시장 규모, 점유율, 성장 분석 : 서비스별, 단계별, 시험 디자인별, 적응증별, 스폰서별, 지역별 - 산업 예측(2025-2032년)

Clinical Trials Support Services Market Size, Share, and Growth Analysis, By Service, By Phase, By Study Design, By Indication, By Sponsor, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 219 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

임상시험 지원 서비스 2023년 시장 규모는 230억 달러로, 2024년 248억 4,000만 달러에서 2032년에는 459억 8,000만 달러로 확대하며, 예측 기간(2025-2032년)의 CAGR은 8.0%로 성장할 전망입니다.

임상시험 업계는 특히 COVID-19 이후 임상시험, 분석 설계, 지원 서비스에 중점을 두고 괄목할 만한 진화를 이루었습니다. 임상시험용 의약품의 확보 및 보관, 임상시험 시설의 안전 확보, 약물 투여량 계산, 키트 관리 등 필수적인 업무가 이 분야에서 중요한 역할을 하고 있습니다. 특히 2021년 COVID-19 백신 개발 이후 연기되었던 많은 임상시험이 재개되면서 신흥 국가 시장에서 증가하는 만성질환, 전염병, 열대성 질환에 대응하기 위한 혁신적인 의약품에 대한 긴급한 필요성도 부각되고 있습니다. 또한 가상 임상시험으로의 전환이 임상시험 지원 서비스 매출 성장의 주요 원동력으로 부상하고 있으며, 연구 회사들은 임상 연구 방법의 효율성을 높이기 위해 가상 기술 채택을 늘리고 있습니다.

목차

서론

  • 조사의 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차와 1차 데이터 방법
  • 시장 규모 예측
  • 시장의 전제조건과 제한

개요

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 촉진요인과 기회
    • 억제요인과 과제
  • Porter의 산업 분석

주요 시장 인사이트

  • 주요 성공 요인
  • 경쟁의 정도
  • 주요 투자 기회
  • 시장 에코시스템
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제 지표
  • 밸류체인 분석
  • 가격 분석

임상시험 지원 서비스 시장 규모 : 서비스별 & CAGR(2025-2032)

  • 시장 개요
  • 관리 스탭
  • 임상시험 시설 관리
    • 환자 모집 및 등록 서비스
    • 환자 모집 관리
    • 환자 유지
  • 데이터 관리
  • 기관 심사 위원회

임상시험 지원 서비스 시장 규모 : 단계별 & CAGR(2025-2032)

  • 시장 개요
  • 단계 I
  • 단계 II
  • 단계 III
  • 단계 IV

임상시험 지원 서비스 시장 규모 : 시험 디자인별 & CAGR(2025-2032)

  • 시장 개요
  • 확장 액세스
  • 개입적
  • 관찰적

임상시험 지원 서비스 시장 규모 : 적응증별 & CAGR(2025-2032)

  • 시장 개요
  • 자가면역 또는 염증
  • 심장혈관
  • 당뇨병
  • 종양학

임상시험 지원 서비스 시장 규모 : 스폰서별 & CAGR(2025-2032)

  • 시장 개요
  • 의료기기
  • 의약품·바이오의약품

임상시험 지원 서비스 시장 규모 : 지역별 & CAGR(2025-2032)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽 지역
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카 지역
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5사의 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채택한 전략
  • 최근 시장 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업의 기업 개요
    • 기업의 상세
    • 제품 포트폴리오 분석
    • 기업의 부문별 점유율 분석
    • 매출의 전년대비 비교(2022-2024)

주요 기업 개요

  • Laboratory Corporation of America Holdings(LabCorp)(USA)
  • Charles River Laboratories International, Inc.(USA)
  • Syneos Health, Inc.(USA)
  • Parexel International Corporation(USA)
  • ICON plc(Ireland)
  • Wuxi AppTec Co., Ltd.(China)
  • Eurofins Scientific(Luxembourg)
  • ACM Global Laboratories(USA)
  • Clinipace Worldwide(USA)
  • Worldwide Clinical Trials(USA)
  • Premier Research(USA)
  • PSI CRO AG(Switzerland)
  • Novotech(Australia)
  • Velocity Clinical Research(USA)
  • Fortrea(USA)
  • CTI Clinical Trial and Consulting Services(USA)

결론과 제안

KSA 25.04.18

Clinical Trials Support Services Market size was valued at USD 23.0 billion in 2023 and is poised to grow from USD 24.84 billion in 2024 to USD 45.98 billion by 2032, growing at a CAGR of 8.0% during the forecast period (2025-2032).

The clinical trials industry has witnessed significant evolution, particularly post-pandemic, with an emphasis on clinical testing, assay design, and support services. Essential operations such as securing and storing research medications, safeguarding trial sites, calculating drug dosages, and managing kits play a vital role in this domain. The resurgence of numerous postponed trials, particularly after the development of COVID-19 vaccines in 2021, has also highlighted the urgent need for innovative pharmaceuticals to address rising chronic, infectious, and tropical diseases in emerging markets. Additionally, the shift towards virtual clinical trials has emerged as a key driver of revenue growth in clinical trial support services, as research firms increasingly adopt virtual technologies to enhance the efficiency of their clinical research processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Trials Support Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Trials Support Services Market Segments Analysis

Global Clinical Trials Support Services Market is segmented by Service, Phase, Study Design, Indication, Sponsor and region. Based on Service, the market is segmented into Administrative Staff, Clinical Trial Site Management, Data Management and Institutional Review Boards. Based on Phase, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on Study Design, the market is segmented into Expanded Access, Interventional and Observational. Based on Indication, the market is segmented into Autoimmune or Inflammation, Cardiovascular, Diabetes and Oncology. Based on Sponsor, the market is segmented into Medical Devices and Pharmaceutical & Biopharmaceutical. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Trials Support Services Market

The growth of the Clinical Trials Support Services market is primarily driven by several key factors, including the increasing prevalence of infectious and chronic diseases, which necessitates extensive research efforts. Additionally, pharmaceutical companies are investing significantly in research and development, further fueling market expansion. The rise of contract research organizations (CROs) is also contributing to this trend, as they offer specialized expertise and resources for conducting clinical trials. Furthermore, the escalating demand for clinical trials in emerging markets is creating new opportunities, ultimately driving the overall growth and evolution of the Clinical Trials Support Services landscape.

Restraints in the Clinical Trials Support Services Market

The growth of the Clinical Trials Support Services market is hindered by insufficient medical infrastructure and advanced technological equipment. Moreover, strict regulations surrounding patient recruitment and the absence of robust management frameworks for the trials pose significant challenges to the market's overall development. However, there remains a promising opportunity for growth driven by the globalization of clinical trials and continuous advancements in technology resulting from ongoing research and development efforts. Addressing these constraints could pave the way for a more dynamic market environment, fostering innovation and improving the efficiency of clinical trial processes.

Market Trends of the Clinical Trials Support Services Market

The Clinical Trials Support Services market is poised for significant growth due to several key trends. The increasing demand for clinical trials in emerging nations, propelled by improved regulatory frameworks and healthcare infrastructure, is driving expansion. Additionally, rising research and development (R&D) investments from pharmaceutical companies, largely fueled by patent expirations, are escalating the need for efficient trial execution. The proliferation of contract research organizations (CROs) further enhances this trend, as they offer specialized services that streamline the trial process and reduce costs. Collectively, these factors indicate a robust and rapidly expanding global market for clinical trials support services.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Clinical Trials Support Services Market Size by Service & CAGR (2025-2032)

  • Market Overview
  • Administrative Staff
  • Clinical Trial Site Management
    • Patient Recruitment & Registry Services
    • Patient Recruitment Management
    • Patient Retention
  • Data Management
  • Institutional Review Boards

Global Clinical Trials Support Services Market Size by Phase & CAGR (2025-2032)

  • Market Overview
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Global Clinical Trials Support Services Market Size by Study Design & CAGR (2025-2032)

  • Market Overview
  • Expanded Access
  • Interventional
  • Observational

Global Clinical Trials Support Services Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Autoimmune or Inflammation
  • Cardiovascular
  • Diabetes
  • Oncology

Global Clinical Trials Support Services Market Size by Sponsor & CAGR (2025-2032)

  • Market Overview
  • Medical Devices
  • Pharmaceutical & Biopharmaceutical

Global Clinical Trials Support Services Market Size & CAGR (2025-2032)

  • North America (Service, Phase, Study Design, Indication, Sponsor)
    • US
    • Canada
  • Europe (Service, Phase, Study Design, Indication, Sponsor)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Service, Phase, Study Design, Indication, Sponsor)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Service, Phase, Study Design, Indication, Sponsor)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Service, Phase, Study Design, Indication, Sponsor)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Laboratory Corporation of America Holdings (LabCorp) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories International, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Syneos Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Parexel International Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICON plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wuxi AppTec Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ACM Global Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Clinipace Worldwide (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Worldwide Clinical Trials (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Premier Research (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PSI CRO AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novotech (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Velocity Clinical Research (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fortrea (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CTI Clinical Trial and Consulting Services (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제